Latest Dr. Falk Pharma GmbH Stories
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
SEOUL, South Korea, June 13, 2011 /PRNewswire/ -- Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH announced positive results from an initial safety and efficacy portal hypertension study in man using udenafil, its new long-active phosphodiesterase inhibitor.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.